Portage, MI, United States of America

Tim Parker



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2011)
  • Portage, MI (US) (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tim Parker: Advancing Treatment for Metabolic Diseases

Introduction: Tim Parker is an innovative inventor based in Portage, MI, known for his contributions to the field of metabolic disease treatment. With a total of two patents to his name, his work focuses on the development of thiazolidinedione analogues, which play a significant role in treating conditions such as hypertension, diabetes, and inflammatory diseases.

Latest Patents: Tim Parker's latest patents revolve around thiazolidinedione analogues designed for the treatment of metabolic diseases. These inventions emphasize the therapeutic potential of thiazolidinedione analogues, which can be utilized to address various health concerns associated with metabolic disorders. The patents detail a specific formula (I), identifying the compounds' constituents, where each of Rand Ris can be independently selected from H, halo, aliphatic, and alkoxy groups, with detailed descriptions of their potential variations.

Career Highlights: Tim is associated with Metabolic Solutions Development Company, LLC, where he channels his expertise into developing innovative solutions for metabolic diseases. His dedication to research and innovation has led to significant breakthroughs in treatment methodologies, improving the quality of life for many patients suffering from these conditions.

Collaborations: In his career, Tim Parker collaborates with notable colleagues, including Gerard R Colca and Robert C Gadwood. Together, they work on advancing research in metabolic diseases, showcasing the importance of teamwork in scientific innovation.

Conclusion: Tim Parker's contributions to the realm of metabolic disease treatment through his innovative thiazolidinedione analogues reflect his commitment to healthcare innovation. His work not only highlights his capabilities as an inventor but also underscores the collaborative efforts within the industry that drive progress in medical research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…